[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"FemPulse Corporation\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":55},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100053933","evaluation-of-a-non-implanted-electrical-stimulation-device-for-overactive-bladder-oab-100053933",false,"NCT07195656","Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)","Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB) EVANESCE-II","EVANESCE-II","Key Inclusion Criteria:\n\n* Females, defined as a person with a uterus and cervix, ≥21 years old, with a diagnosis of OAB and symptoms for more than 6 months, as confirmed by a physician. OAB is defined by urinary urgency, usually with urinary frequency and nocturia, with or without urgency urinary incontinence with symptoms\n* Willing and able to comply with study required procedures and visits (e.g., maintaining consistent medication use, fluid intake, diary completion).\n\nKey Exclusion Criteria:\n\n* Systemic condition or disease that may interfere with study participation (e.g., current systemic infection, uncontrolled autoimmune disease, uncontrolled immunodeficiency disease, history of myocardial infarction, etc.) as determined by study investigator.\n* Not an appropriate study candidate as determined by investigator.","FEMALE","21 Years",{"count":20,"type":21},151,"ESTIMATED","INTERVENTIONAL",[24],"NA","A study to evaluate the safety and effectiveness of FemPulse System",[27],"Overactive Bladder (OAB)",[29],"neuromodulation","RECRUITING","2026-07-10",{"date":33,"type":34},"2026-07-13","ACTUAL",{"date":36,"type":34},"2025-09-30",{"date":38,"type":21},"2027-12-31",{"name":40,"class":41},"FemPulse Corporation","INDUSTRY",15,{"id":44,"slug":4,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":45,"targetDuration":4,"studyType":22,"phases":46,"briefSummary":25,"conditions":47,"keywords":48,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":49,"lastUpdatePostDateStruct":50,"startDateStruct":52,"completionDateStruct":53,"leadSponsor":54,"locationsCount":42},"100607984",{"count":20,"type":21},[24],[27],[29],"2026-02-04",{"date":51,"type":34},"2026-02-06",{"date":36,"type":34},{"date":38,"type":21},{"name":40,"class":41},""]